Daiichi Vows Action As $41.8m Patent Decision Favors Seagen

‘039 Claims Also Now Under Review

A US jury decision in a long-running ADC patent dispute between Seagen and Daiichi Sankyo has found in favor of the US firm. But Daiichi has vowed to challenge the outcome while its motion to question the validity of the original patent on which the case is based has also just been granted, meaning the final impact remains uncertain.

Breast Cancer Awareness: Microscopic image (photomicrograph) of core biopsy for infiltrating (invasive) ductal carcinoma, detected by screening mammogram. H & E stain.
New legal decision as breast cancer rivals set for market battle • Source: Shutterstock

More from Legal & IP

More from Business